Log in to save to my catalogue

Targeting the Glutamatergic System to Treat Pathological Gambling : Current Evidence and Future Pers...

Targeting the Glutamatergic System to Treat Pathological Gambling : Current Evidence and Future Pers...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4075088

Targeting the Glutamatergic System to Treat Pathological Gambling : Current Evidence and Future Perspectives

About this item

Full title

Targeting the Glutamatergic System to Treat Pathological Gambling : Current Evidence and Future Perspectives

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

Journal title

BioMed research international, 2014-01, Vol.2014 (2014), p.1-11

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

More information

Scope and Contents

Contents

Pathological gambling or gambling disorder has been defined by the DSM-5 as a behavioral addiction. To date, its pathophysiology is not completely understood and there is no FDA-approved treatment for gambling disorders. Glutamate is the principal excitatory neurotransmitter in the nervous system and it has been recently involved in the pathophysio...

Alternative Titles

Full title

Targeting the Glutamatergic System to Treat Pathological Gambling : Current Evidence and Future Perspectives

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4075088

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4075088

Other Identifiers

ISSN

2314-6133

E-ISSN

2314-6141

DOI

10.1155/2014/109786

How to access this item